<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJMI</journal-id><journal-title-group><journal-title>Open Journal of Medical Imaging</journal-title></journal-title-group><issn pub-type="epub">2164-2788</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojmi.2022.121001</article-id><article-id pub-id-type="publisher-id">OJMI-115773</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Computed Tomography Findings and Clinico-Epidemiological Aspects of COVID-19 Pneumonia at CHME Luxembourg in Bamako (Mali)
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Alassane</surname><given-names>Kouma</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Souleymane</surname><given-names>Sanogo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Issa</surname><given-names>Cissé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ousmane</surname><given-names>Traoré</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ilias</surname><given-names>Guindo</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ouncoumba</surname><given-names>Diarra</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamadou</surname><given-names>Dembélé</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Seydou</surname><given-names>Ly</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mahamane</surname><given-names>Mariko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamoudou</surname><given-names>Camara</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Siaka</surname><given-names>Sidibé</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib></contrib-group><aff id="aff6"><addr-line>Medical Imaging Department of the CHU Point G, Bamako, Mali</addr-line></aff><aff id="aff1"><addr-line>Medical Imaging Department of CHME Luxembourg, Bamako, Mali</addr-line></aff><aff id="aff3"><addr-line>Department of Medical Imaging of the CHU of Kati, Bamako, Mali</addr-line></aff><aff id="aff2"><addr-line>Marie Curie Clinic, Bamako, Mali</addr-line></aff><aff id="aff4"><addr-line>Department of Medical Imaging of CSREF CIII, Bamako, Mali</addr-line></aff><aff id="aff5"><addr-line>Medical clinic Fertilia, Bamako, Mali</addr-line></aff><pub-date pub-type="epub"><day>10</day><month>03</month><year>2022</year></pub-date><volume>12</volume><issue>01</issue><fpage>1</fpage><lpage>8</lpage><history><date date-type="received"><day>10,</day>	<month>January</month>	<year>2022</year></date><date date-type="rev-recd"><day>7,</day>	<month>March</month>	<year>2022</year>	</date><date date-type="accepted"><day>10,</day>	<month>March</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Objective: To describe the CT findings and clinico-epidemiological aspects of coronavirus pulmonary lesions at the Radiology Department of Mother-Child Luxembourg’s Hospital in Bamako, West Africa. 
  Materials and Method: This was a cross-sectional descriptive study over a period of three months (November 2020-January 2021). The study involved all patients with a clinical suspicion of COVID-19 or confirmed cases with suggestive CT scan lesions during this period. No patients without suggestive CT lesions were not included. The variables were age, sex, clinical data, lungs lesions on CT scan and their severity. 
  Results: Out of 202 patients enlisted, the age group 52 - 63 years was more frequent (30.2%), 
  <em>i.e.</em> an average age of 60.43 years (range 23 and 95 years). Men represented 56.4% or a sex ratio of 1.3. Cough was the most common clinical manifestations (26.7%). Major findings were mixed appearance of the lung lesions (45.5%). The peripheral distribution was 57.4% and the bilateral topography was 98%. These lesions were extensive in the majority of our patients with 28.2%. 
  Conclusion: Older people dominated the socio-demographic profile of our series with a predominance of men. Cough was the most observed clinical information. Mixed lesions with peripheral and bilateral distribution dominated the semiological tomodensitometric aspects. By severity, extensive lung lesions were the most commonly observed.
 
</p></abstract><kwd-group><kwd>COVID-19</kwd><kwd> CT Scan</kwd><kwd> Mixed Lesion</kwd><kwd> Cough</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>SARS-CoV-2 is a new coronavirus that broke up in December 2019 in Wuhan, China. This virus quickly spread around the world resulting in a pandemic with attendant global health crisis [<xref ref-type="bibr" rid="scirp.115773-ref1">1</xref>]. The definitive diagnosis of COVID-19 is provided by the Real-Time Polymerase Chain Reaction (RT-PCR) test, which is the gold standard. It is performed on nasopharyngeal secretions taken by swabbing, and can be weakly positive from the start on the first sample [<xref ref-type="bibr" rid="scirp.115773-ref2">2</xref>]. It is therefore often necessary to repeat the samples in the event of a negative result when the clinical suspicion is very strong, which raises the difficulty of false negative cases. In addition, the result of the examination may only be available within 6 to 48 hours at the earliest, with a sensitivity of between 59% and 83% [<xref ref-type="bibr" rid="scirp.115773-ref2">2</xref>].</p><p>Chest imaging has demonstrated its valuable role in the development of this lung disease. In particular, it has proven its effectiveness in the event of respiratory symptoms requiring hospital treatment to refer patients to COVID-19 or non-COVID-19 units, in anticipation of the results of the RT-PCR [<xref ref-type="bibr" rid="scirp.115773-ref3">3</xref>]. Both x-ray and CT scan of the thoraco-pharyngeal regions are helpful in arriving at diagnosis of the disease. X-Ray has the advantage of lesser radiation dose but its specificity is low [<xref ref-type="bibr" rid="scirp.115773-ref4">4</xref>]. Computed tomography scan, on the other hand, although with higher dose, has both higher sensitivity and specificity and can provide 3-dimensional reconstructions [<xref ref-type="bibr" rid="scirp.115773-ref5">5</xref>]. The Radiology Department of the Luxembourg Mother-Child Hospital in Bamako was equipped with a CT scanner in addition to other modalities. The computed tomography (CT) results observed in the context of COVID-19 pneumonia show a high sensitivity but are however not specific to this pathology [<xref ref-type="bibr" rid="scirp.115773-ref3">3</xref>].</p><p>The objective of this study was to describe the CT findings and clinico-epidemiological aspects of coronavirus pulmonary lesions in our department.</p></sec><sec id="s2"><title>2. Materials and Method</title><p>This was a cross-sectional descriptive study over a three-month period from November 2020 to January 2021 at the Radiology Department of the Luxembourg Mother-Child Hospital in Bamako. The study involved all patients with a clinical suspicion of COVID-19 with suggestive CT lesions and patients with a positive Covid test (RT PCR) during the study period. All patients without suggestive CT lesions were not included. For this work, we received the consent of the head of department.</p><p>The socio-demographic data and essential information for this study were collected through pre-established forms for this purpose. This data collection was made from the CT scan request form for each patient. The CT results were entered directly on the forms after the images were analyzed on the console. The variables analyzed were patient age, patient sex, clinical data, CT lung lesions and severity of these lesions.</p><p>The CT scan examination was performed using a 16-slice Hitachi scanner and according to the method described by Sidi and Elugwu [<xref ref-type="bibr" rid="scirp.115773-ref6">6</xref>]. Exploration was performed without and with intravenous injection of contrast product depending on the clinical context. The images were analyzed in the parenchymal and bone window.</p><p>We took ethical aspects into account during our study. Image anonymity feature was activated to shield patients’ data from third parties. This was done on the CT console in line with the method of Adejoh, et al. [<xref ref-type="bibr" rid="scirp.115773-ref7">7</xref>]. In addition, the confidentiality of the results of each patient was respected.</p><p>Data analysis was done with the aid of SPSS version 20.</p></sec><sec id="s3"><title>3. Results</title><p>A total of 202 patients were enlisted. Patients’ ages ranged from 23 to 95 years with a mean of 60 years. The 52 - 63 years age range made up 30.2% (n = 61) of the entire group. There were more male patients 56.4% (n = 114), than female. The clinical information was dominated by cough with 26.7% (n = 54). These details are summarized in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>Mixed appearance of lesions was the most common with 45.5% (n = 92). Lung lesions were more frequent in the periphery with 57.4% (n = 116). They were bilateral in the majority of patients with 98% (n = 198).This is shown in <xref ref-type="table" rid="table2">Table 2</xref> and <xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig2">Figure 2</xref>.</p><p>As shown in <xref ref-type="table" rid="table3">Table 3</xref>, there were moderate, extended and severe levels of severity of the lesions.</p></sec><sec id="s4"><title>4. Discussion</title><p>As a limit, our study is intra-hospital, taking into account only the patients having performed the thoracic CT imaging. However, it contributes to the enrichment of the scientific literature because very few studies have been carried out in our country on the radiological aspects of COVID-19.</p><sec id="s4_1"><title>4.1. Sociodemographic Profile</title><p>The most common age group was 52 - 63 years with 30.2% (n = 61). The average age was 60.43 years with extremes at 23 years and 95 years. Men were more affected with 56.4% (n = 114) or a sex ratio of 1.3. According to Caruso et al. reported 83 men against 75 women with an average age of 57 years in a series of 158 cases [<xref ref-type="bibr" rid="scirp.115773-ref8">8</xref>]. In their series of 121 patients, Bernheim and al found 61 men and 60 women with a mean age of 45 years [<xref ref-type="bibr" rid="scirp.115773-ref9">9</xref>].</p><p>Shi et al. reported 51% of patients ≤ 50 years old in their study of 81 cases with a predominance of men, i.e. 52% against 48% of women [<xref ref-type="bibr" rid="scirp.115773-ref10">10</xref>]. Most of the authors observed a male predominance in their studies as observed in our series.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Sociodemographic and clinical data</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Sociodemographic and clinical data</th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Gender</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >114</td><td align="center" valign="middle" >56.4</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >88</td><td align="center" valign="middle" >43.6</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >202</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Age groups</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >≤32 years</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >1.5</td></tr><tr><td align="center" valign="middle" >33 - 42 years</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >5.4</td></tr><tr><td align="center" valign="middle" >43 - 52 years</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >18.3</td></tr><tr><td align="center" valign="middle" >53 - 62 years</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >30.2</td></tr><tr><td align="center" valign="middle" >63 - 72 years</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >28.2</td></tr><tr><td align="center" valign="middle" >73 - 82 years</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >14.4</td></tr><tr><td align="center" valign="middle" >≥83 years</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2.0</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >202</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Clinical information</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Cough</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >26.7</td></tr><tr><td align="center" valign="middle" >Several symptoms</td><td align="center" valign="middle" >47</td><td align="center" valign="middle" >23.3</td></tr><tr><td align="center" valign="middle" >Dyspnea</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >21.3</td></tr><tr><td align="center" valign="middle" >Chest pain</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >12.9</td></tr><tr><td align="center" valign="middle" >Embolism suspicion</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >5.9</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >5.4</td></tr><tr><td align="center" valign="middle" >Fever</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >4.5</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >202</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Semiological analysis on CT scan</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Semiological analysis on CT</th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Aspects of lesions</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Mixed</td><td align="center" valign="middle" >92</td><td align="center" valign="middle" >45.5</td></tr><tr><td align="center" valign="middle" >Frosted glass</td><td align="center" valign="middle" >79</td><td align="center" valign="middle" >39.1</td></tr><tr><td align="center" valign="middle" >Crazy paving</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >10.4</td></tr><tr><td align="center" valign="middle" >Condensation</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >3.5</td></tr><tr><td align="center" valign="middle" >Nodular aspect</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.0</td></tr><tr><td align="center" valign="middle" >Inverted halo</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >202</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Distribution of lesions</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Peripheral</td><td align="center" valign="middle" >116</td><td align="center" valign="middle" >57.4</td></tr><tr><td align="center" valign="middle" >Mixed</td><td align="center" valign="middle" >86</td><td align="center" valign="middle" >42.6</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >202</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Localisation of lesions</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Bilateral</td><td align="center" valign="middle" >198</td><td align="center" valign="middle" >98.0</td></tr><tr><td align="center" valign="middle" >Unilateral</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2.0</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >202</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> CT scan classification of lesions according to severity</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >CT Scan Severity</th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Minimal (&lt;10%)</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >7.9</td></tr><tr><td align="center" valign="middle" >Moderate (10% - 25%)</td><td align="center" valign="middle" >55</td><td align="center" valign="middle" >27.2</td></tr><tr><td align="center" valign="middle" >Extended (25% - 50%)</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >28.2</td></tr><tr><td align="center" valign="middle" >Severe (50% - 75%)</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >25.7</td></tr><tr><td align="center" valign="middle" >Critical (&gt;75%)</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >10.9</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >202</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><p>The mean age of patients varies from author to author in the reviewed literature.</p></sec><sec id="s4_2"><title>4.2. Clinical Information</title><p>The clinical information was dominated by cough with 26.7% (n = 54). For Boly and al, cough was the most frequent, ie 60.8% followed by fever with 47.6% [<xref ref-type="bibr" rid="scirp.115773-ref11">11</xref>]. In their work, Samak&#233; and al observed a predominance of cough and fever with 17.06% each [<xref ref-type="bibr" rid="scirp.115773-ref12">12</xref>]. However Kon&#233; and al reported a predominance of dyspnea 11.36% (15/132) and fever 3.03% (4/132) [<xref ref-type="bibr" rid="scirp.115773-ref13">13</xref>]. A wide spectrum of clinical manifestations can be seen with COVID-19. Fever (80.4%), cough (63.1%), tired (46%) and sputum (41.8%) are the most common manifestations of COVID-19 [<xref ref-type="bibr" rid="scirp.115773-ref14">14</xref>].</p></sec><sec id="s4_3"><title>4.3. CT Semiological Analysis</title><p>Mixed appearance of lesions was the most common with 45.5% (n = 92). Lung lesions were more frequent in the periphery with 57.4% (n = 116). They were bilateral in the majority of patients with 98% (n = 198). A wide variety of lung lesions have been described for COVID-19 on chest CT. The most common CT manifestations and their characteristics include frosted glass opacities (87%), bilateral lesion involvement (80%), peripheral distribution (75%), multilobar involvement (89%), posterior topography of the lesions (80%) and parenchymal condensations (33%) [<xref ref-type="bibr" rid="scirp.115773-ref3">3</xref>]. The most characteristic CT abnormalities of COVID-19 pneumonia are areas of ground glass (approximately 80% of cases), multifocal, bilateral, asymmetric. The involvement classically predominates in the peripheral, posterior and basal regions [<xref ref-type="bibr" rid="scirp.115773-ref15">15</xref>]. Yu et al. claimed that with regard to the different types of pulmonary opacities, most patients showed mixed lesions (ground glass and union) in both study groups (27 of 50, 54%) and group 2 (11 of 20, 55%) [<xref ref-type="bibr" rid="scirp.115773-ref16">16</xref>]. Bernheim et al. report a predominance of round lesions, i.e. 54% in a series of 121 [<xref ref-type="bibr" rid="scirp.115773-ref5">5</xref>]. According to these same authors, the peripheral distribution predominated with 52% [<xref ref-type="bibr" rid="scirp.115773-ref9">9</xref>]. Most of the patients had bilateral pulmonary involvement, both central and peripherally distributed. The pure central distribution of lesions and unilateral pulmonary localization was rare [<xref ref-type="bibr" rid="scirp.115773-ref16">16</xref>].</p></sec><sec id="s4_4"><title>4.4. CT Severity of Lung Lesions</title><p>The main CT sign of severity is the extent of parenchymal abnormalities on the initial CT scan. The Thoracic Imaging Society (SIT) therefore recommends grading the parenchymal involvement according to a visual classification in 5 stages, based on the percentage of injured lung: absent or minimal (&lt;10%), moderate (10% - 25%), extensive (25% - 50%), severe (50% - 75%) or critical (&gt; 75%) [<xref ref-type="bibr" rid="scirp.115773-ref15">15</xref>]. In our study, the lesions were classified as extensive in the majority of patients with 28.2% (n = 57). Frederick Tshibasu Tshienda and al stated that assessment of the extent of the lesion revealed a predominance of severe involvement in 34.61%, followed by critical involvement in [<xref ref-type="bibr" rid="scirp.115773-ref17">17</xref>]. According to Madi and al, the extent of the lesions was dominated by severe (37%) and extensive (37%) involvement, followed by critical involvement (14%) [<xref ref-type="bibr" rid="scirp.115773-ref18">18</xref>]. This discrepancy between our result and that of these authors could be related to the immune conditions of the patients, comorbid factors and the type of virus variant according to each geographic region.</p></sec></sec><sec id="s5"><title>5. Conclusion</title><p>The socio-demographic profile of our series was dominated by older people with a predominance of men in whom cough was the most observed clinical information. Medical imaging such as, CT scan, is a key pillar in the management of COVID-19. The semiological tomodensitometric aspects were dominated by mixed lesions with peripheral and bilateral distribution. Extensive lung lesions were the most common according to severity.</p></sec><sec id="s6"><title>Author Approval</title><p>All authors agree to the submission of this article.</p></sec><sec id="s7"><title>Consent</title><p>For this work, we received the consent of the patient as well as that of the head of department.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s9"><title>Cite this paper</title><p>Kouma, A., Sanogo, S., Ciss&#233;, I., Traor&#233;, O., Guindo, I., Diarra, O., Demb&#233;l&#233;, M., Ly, S., Mariko, M., Camara, M. and Sidib&#233;, S. (2022) Computed Tomography Findings and Clinico-Epide- miological Aspects of COVID-19 Pneumonia at CHME Luxembourg in Bamako (Mali). Open Journal of Medical Imaging, 12, 1-8. https://doi.org/10.4236/ojmi.2022.121001</p></sec></body><back><ref-list><title>References</title><ref id="scirp.115773-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Boniface, M., Roger, M.T.J., éric, M.T., Tambe, J., Michel, T.S. and David, T.Z. (2020) Management of the COVID-19 Epidemic: Feedback from a Medical Imaging Center in Sub-Saharan Africa (Yaoundé, Cameroon). African Journal of Medical Imaging, 12, 183-93.</mixed-citation></ref><ref id="scirp.115773-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Onana, Y., Ndongo, F.A., Amougou, J.-C.M., Tambe, J., Tamchom, D.D., Mbozo’o, S., et al. (2021) Value of the Chest Scanner in the Diagnosis of COVID-19 at the Gyneco-Obstetric and Pediatric Hospital of Douala. Health Sciences and Disease, 22, 33-9.</mixed-citation></ref><ref id="scirp.115773-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Mahsouli, A., Grillo, M., Amini, N., Acid, S., Coche, E. and Ghaye, B. (2020) Chest imaging of COVID-19. Leuven Medical, 139, 360-367.</mixed-citation></ref><ref id="scirp.115773-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Adejoh, T., Ezeh, H.C., Aronu, M.E., Nzotta, C.C. and Nwefuru, S.O. (2017) A Technique for Appropriate Inferior Collimation in Chest Radiography of Asymptomatic Negroid Adults. West African Journal of Radiology, 24, 52-55. https://doi.org/10.4103/1115-3474.198108</mixed-citation></ref><ref id="scirp.115773-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Adejoh, T. and Nzotta, C.C. (2016) Head Computed Tomography: Dose Output and Relationship with Anthropo-Technical Parameters. West African Journal of Radiology, 23, 113-117. https://doi.org/10.4103/1115-3474.179256</mixed-citation></ref><ref id="scirp.115773-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Sidi, M. and Elugwu, C.H. (2020) Quantification of Scattered Radiation to Adult Female Breasts during Lumbosacral X-Ray and Head Computed Tomography in a Negroid Population. Pakistan Journal of Radiology, 33, 25-33.</mixed-citation></ref><ref id="scirp.115773-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Adejoh, T., Ezugwu, E.E., Erondu, F.O., Okeji, M.C., Anumihe, P.O. and Asogwa, C.O. (2021) A Dual-Modality Quantification of Scattered Radiation from Head to Female Breasts during Radiological Investigations in a Tertiary Hospital in Nigeria. The Egyptian Journal of Radiology &amp; Nuclear Medicine, 52, Article No. 240. https://doi.org/10.1186/s43055-021-00610-1</mixed-citation></ref><ref id="scirp.115773-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Caruso, D., Zerunian, M., Polici, M., Pucciarelli, F., Polidori, T., Rucci, C., et al. (2020) Chest CT Features of COVID-19 in Rome, Italy. Radiology, 296, E79-E85. https://doi.org/10.1148/radiol.2020201237</mixed-citation></ref><ref id="scirp.115773-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Bernheim, A., Mei, X., Huang, M., Yang, Y., Fayad, Z.A., Zhang, N., et al. (2020) Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology, 295, 686-691. https://doi.org/10.1148/radiol.2020200463</mixed-citation></ref><ref id="scirp.115773-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Shi, H., Han, X., Jiang, N., Cao, Y., Alwalid, O., Gu, J., et al. (2020) Radiological Findings from 81 Patients with COVID-19 Pneumonia in Wuhan, China: A Descriptive Study. The Lancet Infectious Diseases, 20, 425-434. https://doi.org/10.1016/S1473-3099(20)30086-4</mixed-citation></ref><ref id="scirp.115773-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Boly, A., Dembélé, A.Y., Diarra, S.S., Berthé, I., Koné, B., Koné, A., et al. (2021) Study on the Clinical and Epidemiological Characteristics of the First 1030 Cases of COVID-19 in Mali. Mali Medical, 36, 27-31.</mixed-citation></ref><ref id="scirp.115773-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Samaké, D., Coulibaly, M., Kéita, M., Guindo, O., Dembélé, M., Traoré, A., et al. (2021) COVID-19 in Mopti: Epidemiological, Clinical, Therapeutic and Evolutionary Aspects. Revue Malienne d’Infectiologie et de Microbiologie, 16, 47-51. https://doi.org/10.53597/remim.v16i1.1760</mixed-citation></ref><ref id="scirp.115773-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Koné, B., Dembélé, A.Y., Diarra, S.S., Berthé, I., Boly, A., Koné, M., et al. (2021) Clinical and Epidemiological Characteristics of COVID-19 Deaths in Mali. Mali Medical, 36, 8-13.</mixed-citation></ref><ref id="scirp.115773-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Kwee, T.C. and Kwee, R.M. (2020) Chest CT in COVID-19: What the Radiologist Needs to Know. RadioGraphics, 40, 1848-1865. https://doi.org/10.1148/rg.2020200159</mixed-citation></ref><ref id="scirp.115773-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Lode, B., Jalaber, C., Orcel, T., Morcet-Delattre, T., Crespin, N., Voisin, S., et al. (2020) Imaging of COVID-19 Pneumonia. Diagnostic and Interventional Imaging, 3, 249-258. https://doi.org/10.1016/j.jidi.2020.04.011</mixed-citation></ref><ref id="scirp.115773-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Yu, M., Xu, D., Lan, L., Tu, M., Liao, R., Cai, S., et al. (2020) Thin-Section Chest CT Imaging of COVID-19 Pneumonia: A Comparison Between Patients with Mild and Severe Disease. Radiology: Cardiothoracic Imaging, 2, 1-8. https://doi.org/10.1148/ryct.2020200126</mixed-citation></ref><ref id="scirp.115773-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Tshienda, F.T., Tshikwela, M.L., Risasi, J.-R.M., Situakibanza, H.N.T., Salem, R., Ndjock, P.S.M., et al. (2021) Computed Tomography Lesions in Patients Hospitalized for COVID-19 Pneumonia during the First Wave of the SARS-CoV-2 Pandemic at the University Clinics of Kinshasa (DRC). The Pan African Medical Journal, 39, 1-16. https://doi.org/10.11604/pamj.2021.39.230.29311</mixed-citation></ref><ref id="scirp.115773-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Madi, W., Mejdoub Fehri, S. and Ammar, R. (2022) Role of Chest Computed Tomography in the Diagnosis of Respiratory Infection with COVID-19. Revue des Maladies Respiratoires Actualités, 14, 110. https://doi.org/10.1016/j.rmra.2021.11.141</mixed-citation></ref></ref-list></back></article>